Scientific Reports,
Journal Year:
2024,
Volume and Issue:
14(1)
Published: Dec. 28, 2024
Tumor
heterogeneity,
immune-suppressive
microenvironment
and
the
precise
killing
of
tumor
cells
by
drugs
are
important
factors
affecting
treatment.
In
this
study,
we
developed
environment-responsive
drug
delivery
system
(FM@IQ/PST&ZIF-8/DOX)
based
on
ZIF-8
for
photothermal/immunotherapy/chemotherapy
synergistic
therapy.
The
prepared
FM@IQ/PST&ZIF-8/DOX
nanoplatfrom
not
only
has
highly
loading
capacity
chemotherapeutic
drug-doxorubicin,
but
also
erythrocyte
membrance
modified
their
surface
can
endow
immunity-escaping
property
prolong
blood
circulation
time.
More
important,
neurotransmitter
serotonin
was
encapsulated
ZIF-8/DOX
oxidative
polymerization,
which
effectively
avoid
premature
leakage
DOX
in
circulation.
And
formed
polyserotonin
shell
superior
photothermal
conversion
performance,
as
well
adsorption
utilized
to
load
imiqumod.
When
entered
tissue,
folate
molecules
specifically
bind
receptors
improve
uptake
cells.
vitro
vivo
results
showed
that
nanoplatform
could
generate
a
large
amount
heat
under
near-infrared
light
irradiation,
then
induce
apoptosis
cells,
release
associated
antigens,
solve
problem
heterogeneity.
addition,
loaded
imiquimod
immunosuppressive
microenvironment,
enhance
body's
anti-tumor
immune
response,
inhibit
metastasis
recurrence.
Therefore,
novel
designed
research
achieve
controllable
release,
it
is
expected
become
promising
new
strategy
treatment
provide
corresponding
inspiration
later
development
drugs.
Signal Transduction and Targeted Therapy,
Journal Year:
2024,
Volume and Issue:
9(1)
Published: Aug. 12, 2024
Cancer
remains
a
significant
risk
to
human
health.
Nanomedicine
is
new
multidisciplinary
field
that
garnering
lot
of
interest
and
investigation.
shows
great
potential
for
cancer
diagnosis
treatment.
Specifically
engineered
nanoparticles
can
be
employed
as
contrast
agents
in
diagnostics
enable
high
sensitivity
high-resolution
tumor
detection
by
imaging
examinations.
Novel
approaches
labeling
are
also
made
possible
the
use
nanoprobes
nanobiosensors.
The
achievement
targeted
medication
delivery
therapy
accomplished
through
rational
design
manufacture
nanodrug
carriers.
Nanoparticles
have
capability
effectively
transport
medications
or
gene
fragments
tissues
via
passive
active
targeting
processes,
thus
enhancing
treatment
outcomes
while
minimizing
harm
healthy
tissues.
Simultaneously,
context
radiation
sensitization
photothermal
enhance
therapeutic
efficacy
malignant
tumors.
This
review
presents
literature
overview
summary
how
nanotechnology
used
According
oncological
diseases
originating
from
different
systems
body
combining
pathophysiological
features
cancers
at
sites,
we
most
recent
developments
applications.
Finally,
briefly
discuss
prospects
challenges
cancer.
Journal of Translational Medicine,
Journal Year:
2025,
Volume and Issue:
23(1)
Published: April 29, 2025
Tumor-draining
lymph
nodes
(TDLNs)
are
often
involved
during
the
metastasis
of
bladder
cancer
(BC),
which
is
associated
with
a
poor
prognosis.
Recent
studies
have
shown
that
TDLNs
major
source
host
anti-tumor
immunity,
can
impede
tumor
progression
and
favor
immunotherapy.
However,
progression,
various
tumor-derived
mediators
modulate
TDLN
microenvironment,
impairing
their
protective
function.
Ultimately,
provide
soil
for
proliferation
dissemination
cells.
Therefore,
surgical
removal
commonly
recommended
in
solid
tumors
to
prevent
metastasis,
but
this
poses
significant
challenges
leveraging
Additionally,
node
dissection
(LND)
has
not
survival
benefits
some
tumors.
Hence,
decision
remove
oncological
treatment
needs
be
reconsidered.
Herein,
we
spotlight
BC
introduce
how
cells
stromal
immune
shape
an
immunosuppressive
microenvironment
progression.
We
summarize
existing
therapeutic
strategies
reinvigorate
immunity
TDLNs.
Furthermore,
discuss
whether
preserve
role
LND
treatment.
Frontiers in Immunology,
Journal Year:
2025,
Volume and Issue:
16
Published: April 29, 2025
Introduction
Immune
checkpoint
inhibitors
(ICIs)
have
significantly
improved
survival
for
patients
with
metastatic
melanoma,
yet
many
experienceresistance
due
to
immunosuppressive
mechanisms
within
the
tumor
immune
microenvironment
(TIME).
Understanding
how
spatial
architecture
of
and
inflammatory
components
changes
across
disease
stages
may
reveal
novel
prognostic
biomarkers
therapeutic
targets.
Methods
We
performed
high-dimensional
profiling
two
melanoma
tissue
microarrays
(TMAs),
representing
Stage
III
(
n
=
157)
IV
248)
tumors.
Using
imaging
mass
cytometry
(IMC)
multiplex
immunofluorescence
(mIF),
we
characterized
phenotypic,
functional,
properties
TIME.
Cellular
neighborhoods
were
defined
by
marker
expression,
interactions
between
cells
quantified
using
nearest-neighbor
functions
(G-cross).
Associations
assessed
Cox
proportional
hazards
models
robust
variance
estimation.
Results
tumors
exhibited
a
distinct
landscape,
increased
CD74-
MIF-enriched
reduced
iNOS-associated
regions
compared
III.
Cytotoxic
T
lymphocytes
(CTLs)
more
prevalent
in
TIME,
while
B
NK
depleted.
Spatial
analysis
revealed
that
CTL–Th
cell,
NK–T
B–NK
cell
linked
survival,
whereas
macrophage
aggregation
excessive
B–Th
clustering
correlated
worse
outcomes.
Organ-specific
analyses
showed
CTL
infiltration
near
predicted
gastrointestinal
metastases,
lymph
node
skin
metastases.
Discussion
Our
results
stage-specific
shifts
composition
organization
In
advanced
disease,
emerge
alongside
localization,
patterns
coordination—particularly
involving
CTLs,
cells,
cells—strongly
predicting
survival.
These
findings
highlight
refine
patient
stratification
guide
combination
immunotherapy
strategies
targeting
Frontiers in Molecular Biosciences,
Journal Year:
2025,
Volume and Issue:
11
Published: Jan. 22, 2025
Cytokines
play
a
crucial
role
in
mediating
cell
communication
within
the
tumor
microenvironment
(TME).
Tumor-associated
macrophages
are
particularly
influential
regulation
of
immunosuppressive
cytokines,
thereby
supporting
metastasis.
The
upregulation
Th2
cytokines
cancer
cells
is
recognized
for
its
involvement
suppressing
anticancer
immunity.
However,
association
between
these
and
tumor-secreted
extracellular
vesicles
(EVs)
remains
poorly
understood.
Therefore,
our
objective
was
to
investigate
connection
tumor-promoting
melanoma-derived
EVs.
analysis
from
altered
cytokine
profile
data
showed
that
EVs
upregulate
expression
naïve
macrophages,
contributing
promotion
tumor-supporting
functions.
Notably,
many
were
also
found
be
upregulated
metastatic
melanoma
patients
(n
=
30)
compared
healthy
controls
33).
Overall,
findings
suggest
strong
secretory
induction
tumor-associated
facilitates
development
an
TME,
metastasis
through
at
both
local
systemic
levels.
Cancers,
Journal Year:
2025,
Volume and Issue:
17(8), P. 1281 - 1281
Published: April 10, 2025
The
identification
of
predictive
factors
for
sentinel
lymph
node
(SLN)
positivity
in
melanoma
patients
is
crucial
accurate
staging,
prognosis,
and
personalized
therapeutic
decisions.
This
review
synthesizes
recent
advancements
molecular
clinicopathological
predictors,
with
a
particular
focus
on
liquid
biopsy
gene
expression
profiling
(GEP)
tools.
Emerging
evidence
highlights
the
significant
role
miRNAs
progression,
metastatic
potential,
lymphatic
spread.
Clinicopathological
such
as
Breslow
thickness,
ulceration,
mitotic
rate
remain
critical,
while
GEP
provides
additional
precision
by
uncovering
tumor-specific
pathways.
By
integrating
these
tools,
clinicians
can
improve
risk
stratification,
reduce
unnecessary
procedures,
personalize
management
strategies.
Biomolecules,
Journal Year:
2024,
Volume and Issue:
14(7), P. 837 - 837
Published: July 11, 2024
CD36
expression
in
both
immune
and
non-immune
cells
is
known
to
be
directly
involved
cancer
metastasis.
Extracellular
vesicles
(EVs)
secreted
by
malignant
melanocytes
play
a
vital
role
developing
tumor-promoting
microenvironments,
but
it
unclear
whether
this
mediated
through
CD36.
To
understand
the
of
melanoma,
we
first
analyzed
SKCM
dataset
for
clinical
prognosis,
evaluated
percentage
lymphatic
fluid-derived
EVs
(LEVs),
tested
melanoma-derived
increase
induce
M2-macrophage-like
characteristics.
Furthermore,
performed
multiplex
immunofluorescence
(MxIF)
imaging
analysis
evaluate
its
colocalization
with
various
other
lymph
node
(LN)
patients
control
subjects.
Our
findings
show
that
cutaneous
melanoma
have
worse
prognosis
high
levels,
higher
total
LEVs
were
found
at
baseline
compared
control.
We
also
monocytic
endothelial
treated
expressed
more
than
untreated
cells.
can
regulate
immunosuppressive
macrophage-like
characteristics
upregulating
The
spatial
data
tumor-involved
sentinel
LNs
exhibit
probability
from
LNs,
was
not
statistically
significant.
Conclusively,
our
demonstrated
plays
controlling
microenvironment
LN,
which
promote
formation
protumorigenic
niche.
Advanced Science,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Oct. 30, 2024
Abstract
In
vitro
models
are
crucial
in
cancer
research,
but
they
must
truthfully
mimic
vivo
tumors
for
clinical
relevance.
The
development
of
unprecedent
melanoma
quadruple
multicellular
tumoroids
(MCTs)
is
proposed
comprising
tumor
cells,
keratinocytes,
fibroblasts,
and
monocytes
that
replicate
architecture,
microenvironment,
secretome
behavior.
These
MCTs
300
µm
diameter
secreted
keratin
collagen,
showing
complexity
proportional
to
their
cell
combinations.
Further,
closely
resembled
terms
cells
organization,
growth,
progression,
immune
Drug
screening
using
these
demonstrated
potential
as
patient‐derived
platforms
precision
medicine.
findings
highlight
the
true
value
studying
biology
testing
therapeutic
interventions
with
greater
relevance
human
disease.